How Musculoskeletal Tumor Management Changed During the COVID-19 Pandemic: Data from a Nationwide Questionnaire Survey of Hospitals Specializing in Musculoskeletal Tumors in Japan
The pandemic substantially disrupted outpatient services and surgical care in musculoskeletal oncology. Patient infection was the main driver of treatment strategy modifications.
Authors
- Jun Nishida (ORCID: https://orcid.org/0000-0001-7834-8179)
- Masanori Okamoto (ORCID: https://orcid.org/0000-0003-0351-865X)
- Takaaki Tanaka (ORCID: https://orcid.org/0000-0003-0136-1708)
- Kensaku Yamaga (ORCID: https://orcid.org/0000-0002-0523-6528)
- Shintaro Iwata (ORCID: https://orcid.org/0000-0002-2024-514X)
- Takeshi Morii
- Kosei Ando
Institutions
- University of Fukui (JP)
- Shinshu University (JP)
- Tokyo Medical University (JP)
- Shiga University of Medical Science (JP)
- Kyorin University (JP)
- National Cancer Centre Japan (JP)
- National Cancer Center (US)
- Tottori University (JP)
Publication Details
- Journal
- Current Oncology
- Published
- 2025-08-12
- DOI
- https://doi.org/10.3390/curroncol32080453
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00